Abstract -Contagious bovine pleuropneumonia (CBPP), caused by Mycoplasma mycoides subsp. mycoides biotype Small Colony (MmmSC
INTRODUCTION
Contagious bovine pleuropneumonia (CBPP) caused by Mycoplasma mycoides subsp. mycoides biotype Small Colony (MmmSC), still remains a major cattle disease in Africa [31] . CBPP is the only bacterial disease included in the list A of the Office International des Epizooties (OIE), leading to the exclusion of infected countries from international trade. The disease is responsible for heavy economic losses due 580 L. Dedieu et al. to mortality, loss of weight, reduced working ability or fertility. Based on a combination of a stamping out policy, control of cattle movement and quarantine, CBPP has been eradicated from numerous countries such as Australia, the USA and Europe. However, these measures are impracticable in Africa where nomadism and transhumance are a necessity. In Africa, the only realistic prophylaxis has to rely on vaccination. However, the live attenuated vaccines currently in use, based on the T1 strain, are of low efficacy, requiring annual, costly, vaccination campaigns, and still retain some virulence [23, 31] . The development of more efficient vaccines is therefore an important goal to achieve CBPP eradication from Africa. To this aim, understanding the parameters of the MmmSCspecific host immune protection is an important prerequisite.
Several observations point to a critical role of cell-mediated immunity in the pathogenesis and control of MmmSC infections [24, 25, 32] . Furthermore, a recent study of the MmmSC-induced peripheral blood response revealed the predominant contribution of MmmSC-specific IFNγ-secreting CD4 T-cells to protection against CBPP [5] .
The present study focused on the MmmSC-specific immune response persisting in the lymph nodes of cattle recovered from an MmmSC infection transmitted by the natural route, one year post exposure. The objective was to characterise the MmmSC-specific acquired memory. Indeed, after infection, a pool of antigen-experienced lymphocytes homes to the draining lymph nodes as memory cells [10] [11] [12] 34] . Memory cells play a critical role in longterm immunity and mediate protective immunity against a new challenge [13, 34] . The characterisation of the MmmSC-specific memory immune cell subsets in recovered animals, known to be refractory to new infection, will help identifying the protective mechanism. The development of vaccines expanding these MmmSC-specific memory immune cells will, therefore, provide efficient vaccinal strategy against CBPP.
MATERIALS AND METHODS

Experimental infection
The experimental infection protocol was designed according to the French national legislation for animal experimentation and was performed, in accordance with the same guidelines, at the Central Veterinary Laboratory in Bamako (Mali), as already described [20] . The objective was to reproduce a natural in-contact MmmSC infection. Eleven naive Peulh zebus were taken from CBPP-free areas where they had never been vaccinated against CBPP. These animals were 3 to 6 years old and the sex ratio was 3 females for 8 males (Tab. I). These naïve cattle, identified as the "contact" group, were placed in contact with 8 MmmSCinfected N'dama cattle taken from a field outbreak, 3 to 4 weeks after its onset. These 8 cattle, constituting the "infected" group, were 5 to 7 years old with a sex ratio of 5 females for 3 males (Tab. I). All animals were selected for their negative status for foot and mouth disease, tuberculosis and brucellosis and were dewormed before use. The animals were housed in close contact for 12 months, outdoors during the day and indoors at night.
Temperature and clinical signs were recorded daily. A serological follow up of the MmmSC infection was carried out by the complement fixation test (CFT), recommended by the OIE as the standard serological test for CBPP diagnosis [4] . Animals with respiratory distress were directly sacrificed to reduce suffering, and the remaining animals were post-mortemed at the end of the experiment. During the post mortem (PM) analysis, two lymph nodes (LN), a mediastinal and a tracheobronchic draining the infected lung region, were taken from each animal of the "contact" group and from the two recovered cattle from the "infected" group. Only one LN was taken from all other cattle of the "infected" group.
Lymph node cell preparation
LN were collected in Hanks balanced salt solution (Eurobio, Les Ulis, France) supplemented with 100 U/mL penicillin, 100 µg/mL streptomycin and 250 ng/mL amphotericin B (Sigma, St. Quentin, France) and maintained on ice during transport to the laboratory. The cells were released from the LN, in warm RPMI-1640 culture medium (Eurobio), by slicing the tissues in small pieces with a scalpel. Cells were filtered on gauze, centrifuged and washed with Hanks balanced salt solution without calcium and magnesium (Eurobio), supplemented as above. The LN cells were numbered, resuspended in foetal calf serum (Eurobio) supplemented with 10%DMSO (Sigma), and stored frozen at 2 × 10 7 cells/mL in liquid nitrogen. The cells were maintained frozen in liquid nitrogen during shipment to France.
To assess the non-specific immune response, two LN (mediastinal and tracheobronchic) from four healthy cattle, identified as the "negative control" group, were taken at a slaughterhouse in Montpellier and prepared as described above. Table I . Results of the experimental transmission of an MmmSC infection. Eleven naive cattle ("contact" group) were naturally infected by close contact housing with 8 MmmSC-infected cattle ("infected" group) taken from the field as described in Materials and Methods. The animals were assigned to three groups according to the outcome of the MmmSC infection and intensity of the lung lesions. The sex (f: female; m: male) and age (in years) was indicated for each animal. 
MmmSC strain and growth conditions and antigen preparation
The MmmSC T1 attenuated strain was used for all in vitro stimulation for practical reasons (level 2 confinements). Cultures were as previously described [5] . Heatinactivated MmmSC were obtained after one hour incubation at 60 °C. The MmmSC total proteins in the crude cell suspension were titrated by the bicinchoninic acid method [30] .
Lymphoproliferation assays and cell phenotyping
LN cells were prepared as previously described [5] . One millilitre (2.5 × 10 6 cells/ mL) was then distributed into each well of a 24-well microtitre plate and incubated with heat-inactivated MmmSC (5 µg/mL), concanavalin A (2.5 µg/mL; Sigma) as a positive control to verify cell viability or in RPMI media (negative control), for 5 days at 37 °C with 5% CO 2 .
The cell phenotyping was performed by immunofluorescence staining, as previously described [5] , using specific mouse monoclonal antibodies (MAb) to the following bovine leukocyte antigens: WC1 (CC15, SEROTEC, Cergy St. Christophe, France), CD2 (IL-A26), CD4 (IL-A12), CD8 (IL-A105), major histocompatibility complex class II (MHCII) molecules (J11), interleukin-2 receptor CD25 (IL-A111) [1, 14, 16, 18] . Except for the former, all other MAbs were from the International Livestock Research Institute (ILRI, Nairobi, Kenya). MAb DU 2 -104, kindly provided by W. Hein, was used to detect the B-cells [17] . Flow cytometry analysis, measurement of blastogenesis, of the various cell subsets and of their state of activation (CD25 expression) have already been described [5] .
The MmmSC-responsiveness was investigated by measuring the MmmSC-induced (1) blastogenesis, (2) percentage of CD25 + cells within the total population, (3) percentage of CD25 + cells within the CD4 T-cell subset and (4) IFNγ production.
The relative activation of the CD4 T-cells was also evaluated by measuring the median of fluorescence intensity (MdFI) of the gated CD25+CD4 T-cells. The MmmSCspecific responsiveness was validated if at least 2 of the 4 immune parameters were above cut off values determined from the "negative control" group. These cut off points were defined for each immune parameter as the mean value of MmmSC-induced minus unstimulated data plus 2 standard deviations (SD) among negative control cattle.
IFNγ ELISA
Lymphoproliferation assay supernatants were collected on day 5 to quantify gamma interferon (IFNγ) production using a commercially available enzyme-linked immunosorbent assay (Bovigam γ interferon test, BioCore, Omaha, NE, USA) according to the manufacturer's instructions. Data were expressed as the mean OD units (± SD) of duplicate assays.
Statistical analysis
The unpaired Student t-Test was used for comparative analysis between the "negative control" group and the various groups of "MmmSC-infected" cattle and to compare these groups between themselves. The Paired Student t-Test was used for comparison between in vitro unstimulated and MmmSC-stimulated cells. P-values less than 0.05 were considered significant. P-values less than 0.01 were considered highly significant.
RESULTS
Experimental infection
The results of the experiment are presented in Table I (clinical form, outcome and post mortem (PM) analysis). All animals from either the "contact" or the "infected" group presented clinical signs of an MmmSC infection (temperature, cough, nasal discharge, dyspnoea) accompanied by a significant MmmSC-specific serological response measured by the CFT (data not shown). As shown in Table I , two "contact" cattle died from acute infection (C12, C14) while nine recovered either from a subclinic/chronic form or after an acute clinical period. Unfortunately, the death of the two acutely-infected zebus occurred at night, thus no viable cell samples could be taken. Therefore, in order to study animals succumbing from the infection, six cattle from the "infected" group with acute infection leading to death were included in the study as well as two recovered animals. Although several parameters were different between both groups of cattle, the comparative analysis, according to the epidemiological data discussed below, was assumed to be relevant. The animals were assigned to three groups according to the outcome of the infection and intensity of the lung lesions: group 1: animals with complete recovery (C4, C8, C13, I9, I12), group 2: animals with acute infection leading to death (I1, I2, I4, I5, I6, I11), group 3: recovered animals presenting lung sequestras (C3, C5, C6, C7, C9, C11).
The PM analysis revealed that animals with acute infection were characterised by typical CBPP lesions such as lung hepatisation and large quantities of pleural fluid (C12, C14, I1, I2), large (I4, I5, I11) or multiple sequestra (I6) involving almost completely one lung lobe. Instead recovered animals presented either fibrotic scars (C4, C8, C13, I9, I12) or small sequestra (C5, C6, C7, C11), although 2 cattle showed a medium size sequestra (C3 and C9).
Ex vivo phenotypic analysis of the lymph node cells
The percentage of each cell subset (CD4 and CD8 T-cells, WC1 + γδ T-cells and B-cells) as well as the percentage of activated (CD25 + ) cells was monitored for each LN from each animal. Table II presents the results (mean percentage (± SD) obtained for the three groups compared to the "negative control" group. It shows that animals from group 1 were characterised by a significant increase of both the CD4 and CD8 T-cells compared to the "negative control" group (p < 0.01) but also to groups 2 (p < 0.05) and 3 (p < 0.05). Group 3 was also characterised by a highly significant increase of the CD8 T-cells compared to the "negative control" group (p < 0.01). In parallel, a significant decrease of the B-cells was Table II . Ex vivo phenotypic analysis of the lymph node cells. The mean percentage and standard deviation of each cell subset are presented for the different groups of animals: "negative control" cattle (n = 4), animals with complete recovery (group 1; n = 5), animals with acute infection leading to death (n = 6), animals recovered with persisting lung lesions (n = 6). and ** highly significant difference (p < 0.01) with the "negative control" group. # Significant (p < 0.05) and ## highly significant difference (p < 0.01) with group 1. © Significant (p < 0.05) and ©© highly significant difference (p < 0.01) with group 2. ¤ Significant (p < 0.05) and ¤¤ highly significant difference (p < 0.01) with group 3.
observed in group 1 compared to the "negative control" group (p < 0.05) and to group 2 (p < 0.05) and 3 (p < 0.01). A significant decrease of the γδ T-cells was also noticed in group 1 animals compared to the "negative control" group (p < 0.05). However, group 2 animals were characterised by the lowest percentage of γδ T-cells compared to either the "negative control" group (p < 0.01), group 1 (p < 0.05) or group 3 (p < 0.01). Nevertheless, the very low proportion of the γδ T-cell subset in the cattle lymph nodes has to be noticed. No other difference was measured either between groups 2 or 3 and the "negative control" group or between groups 2 and 3.
The measurement of the CD25-expressing cells revealed a significant decrease in group 3 compared to the "negative control" group (p < 0.01), to group 1 (p < 0.01) and group 2 (p < 0.05).
MmmSC responsiveness of lymph node cells
The MmmSC responsiveness of the LN cells was then compared between the 3 groups of animals. For accurate discrimination between MmmSC-specific and non specific response, cut off values were first determined (Tab. III) with LN cells from the "negative control" group, as described in Materials and methods.
A preliminary analysis was performed on 10 MmmSC-infected cattle to assess whether variability in the MmmSC-specific immune response occurred between the mediastinal and the tracheobronchic LN. The results, shown in Table IV , revealed no significant difference for any of the immune parameter tested. Accordingly, the data from both LN were treated regardless of their origin.
The first finding of the study was that all the MmmSC-infected cattle presented an MmmSC-specific cellular responsiveness except two animals. Indeed, I1 and I2 were unable to develop an in vitro response to MmmSC stimulation, likely due to the severe lung lesions. Both animals were characterised after 5 days of culture by a very low percentage of CD4 T-cells, 6.10 ± 3.73%, while a mean percentage of 25.20 ± 7.26% of CD4 T-cells was observed in all other animals. Figure 1 presents the mean value (+ SD) of each parameter obtained after MmmSC stimulation minus unstimulated control for all the MmmSC-responding samples in each group of animals, after excluding I1 and I2 from group 2. One LN (mediastinal) from animal C8 was also excluded in Table III . Analysis of the MmmSC non-specific responsiveness. Lymph node cells from the "negative control" group cattle were stimulated for 5 days in vitro with MmmSC and the percentage of blastic cells, CD25 + cells, CD4 + CD25 + cells and IFNγ production were determined by flow cytometry and ELISA, respectively. The percentage of CD4 + CD25 + cells was calculated within the CD4 T-cell gate and expressed as a percentage of the CD4 T-cell subset. The ConA responsiveness was indicated as a control. Data are the mean percentage or OD Units (± SD) obtained after stimulation minus the unstimulated control. The cut off values for MmmSC-specific responsiveness were calculated by the mean value obtained for the "control" cattle + 2 SD.
ConA stimulation (% of cells)
MmmSC stimulation (% of cells) Figure 1 shows that MmmSC exposure induced in all the three groups an MmmSCspecific blastogenesis, CD25 expression and IFNγ production. However, the highest level of MmmSC responsiveness was observed in group 1 animals with mean values for each parameter exceeding their respective values in the other two groups. The major finding was the significant increase in the percentage of MmmSC-specific CD25-expressing cells within the CD4 T-cell subset observed in group 1 (30.80 ± 6.98%) compared to the other groups (20.12 ± 4.54% in group 2 (p < 0.05) and 20.01 ± 8.95% in group 3 (p < 0.01)). Measured within the total population, the percentage of MmmSC-specific CD25 + -cells showed no significant difference between the three groups. The increase in blastic cells after MmmSC stimulation was highly significant (p < 0.01) when comparing group 1 (16.77 ± 7.56%) to group 3 (9.06 ± 2.86%) while non significant compared to group 2 (11.29 ± 5.23%). A strong IFNγ production was triggered by MmmSC in all three groups and, although the mean level of production was higher in group 1 (2.01 ± 1.06%), this was not statistically significant compared to group 2 (1.35 ± 0.61%) or group 3 (1.41 ± 0.841%).
Phenotyping of the
MmmSC-responding lymphocytes
A phenotypic study of the MmmSCresponding lymphocytes was then performed on 4 MmmSC-responding lymph nodes within each group. Figure 2 presents the results (mean value ± SD) obtained after MmmSC stimulation compared to unstimulated cultures for the three groups of animals. Before comparing the results between the three groups, a first analysis was performed with the paired Student t-Test to assess the statistical significance of the MmmSC-induced data compared to unstimulated cells. This analysis demonstrated that exposure to MmmSC triggered, in group 1, a significant (p < 0.05) increase of MHCII-bearing cells (74.13 ± 3.36% with MmmSC versus 61.8 ± 8.32% without stimulation). As shown in Figure 2 , this increase might be due in part to B-cells, since all B-cells were expressing MHC II (data not shown), although the MmmSC-induced B-cell proliferation and increase of CD25+B-cells were not statistically significant compared to unstimulated cells. Instead, the significant CD4 T-cell activation observed after MmmSC exposure indicated that these cells were the main MmmSC-responding lymphocytes. Indeed, the CD4 T-cell subpopulation was the only subset presenting a highly significant (p < 0.01) increase in the percentage of CD25 + cells in response to Table IV . Comparative analysis of the MmmSC-specific immune response between the mediastinal and the tracheobronchic lymph nodes. Lymph node cells from the 10 MmmSC-infected cattle, for which both lymph nodes were available, were stimulated for 5 days in vitro with MmmSC and the percentage of blastic cells, CD25 + cells, CD4 + CD25 + cells and IFNγ production were determined by flow cytometry and ELISA, respectively. The percentage of CD4 + CD25 + cells was calculated within the CD4 T-cell gate and expressed as a percentage of the CD4 T-cell subset. Data are the mean percentage or OD Units (± SD) obtained after MmmSC stimulation minus the unstimulated control. Figure 2 . A similar result was observed for the CD25 + CD8 T-cells in 3 samples while the 4th sample showed a strong increase in the CD25 + CD8 T-cell percentage after exposure to MmmSC. For group 2, except for the significant CD4 T-cell activation elicited by MmmSC, no other change was noticed compared to unstimulated cultures. Exposure to MmmSC led to a significant (p < 0.05) increase of the percentage (36.61 ± 11.76% versus 16.50 ± 7.72% in unstimulated cells) and MdFI (112.04 ± 31.70 versus 53.28 ± 10.32 fluorescent units in unstimulated cells) of CD25+CD4 T-cells without cell proliferation. The percentage of CD25+CD8 T-cells was always below the cut off. In contrast to group 1, a decrease of the mean percentage of MHCII-bearing cells, although non significant, was observed after MmmSC stimulation. Moreover, a decrease of the fluorescence intensity of the MHC II cell surface expression, after exposure to MmmSC, was also noticed during flow cytometry analysis (data not shown).
In group 3, MmmSC triggered a significant (p < 0.05) increase of the percentage of MHCII-expressing cells (66.19 ± 3.33%) and CD25+ cells within the B-cell subset (4.79 ± 1.83%), CD4 (37.78 ± 8.93%) and CD8 (31.67 ± 3.81%) T-cell subsets, compared to unstimulated cells (57.98 ± 2.68%, 0.4 ± 0.63%, 24.5 ± 6.76%, 14.9 ± 2.35%, respectively). MmmSC stimulation also led to a significant (p < 0.05) increase of the MdFI of the CD25+CD4 subset (211.24 ± 77.54 fluorescent units versus 135 ± 59.66 fluorescent units without stimulation). As noticed above for groups 1 and 2, no T-cell A comparative analysis of the MmmSCspecific CD4 T-cell activation was then performed between the three groups. The results confirmed that the percentage of CD4 T-cells responding to MmmSC stimulation (CD25-expressing) as well as the relative level of activation of these CD4 T-cells (MdFI) was significantly higher in group 1 (p < 0.05) compared to groups 2 and 3. No significant difference was measured between groups 2 and 3. in animals with lung sequestras is not clear. Although MmmSC have been immunohistochemically detected in macrophages, data are lacking to confirm its viability in any host cell [27, 29] . A by-stander effect of the MmmSC-specific CD4 T-cell response was rather suggested [5] . Further studies are required to assess the cytokine environment and determine whether these cells play a role in protection. Significant γδ T-cell activation was observed in the MmmSC-specific peripheral immune response [5] while it could not be detected in this study. Indeed, while γδ T-cells are a significant component of the afferent and efferent lymph and, in ruminants, may constitute up to 50% of the PBMC in young animals, they are only a minor population within the lymph nodes, suggesting that they re-circulate preferentially through non lymphoid tissues [33] .
Recovery from an MmmSC infection and protection requires thus an MmmSCspecific IFNγ-secreting CD4 T-cell response. Its onset and magnitude but also other immune parameters such as the local immune response, since CBPP is a mucosal disease, are likely to play a role. A recent study demonstrated, indeed, a significant correlation between the presence of MmmSC-specific IgA and an attenuation of the clinical impact of the MmmSC infection 3 . The significantly lower magnitude of the MmmSCspecific IFNγ-secreting CD4 T-cell response detected in the group of cattle recovered but with sequestras might explain this outcome. While likely involved in the process of recovery, this response was not sufficient to efficiently control the MmmSC infection. Nevertheless, sequestras, as granulomas, develop as part of the protective host response to block the deleterious effects of the pathogen [21, 28, 29] . The intensity of the immune response detected in the lymph nodes of some animals succumbing from infection was also significantly lower than in animals with complete recovery. The presence of viable MmmSC in the respiratory lymph nodes, described in acute cases of CBPP [2, 29] , might also have played a role. Indeed, although not proved in vivo, the in vitro ability of viable MmmSC to trigger apoptosis in bovine leucocytes has been demonstrated [6] . The MmmSC unresponsiveness, observed in two cattle with strong acute lung lesions, might represent the final step of this immunopathological process. A correlation between progression of CBPP and a decreased ability of the PBMC to produce IFNγ was previously observed [5] while in this study the lymph node CD4 T-cells were able to produce IFNγ. Unfortunately, data on the kinetic of the blood immune response, but also on the Th1/Th2 balance, are lacking for this group of cattle in order to further unravel the immunopathological mechanism leading to a fatal issue.
The comparative analysis of these groups of animals might be limited by the introduction of different parameters (breeds, age, sex ratio…), however several epidemiological data support this comparison: (1) both breeds, N'Dama cattle and Peulh zebus, belong to the genus Bos and are thus susceptible to naturally occurring CBPP, (2) a full susceptibility to MmmSC infection is described for animals over two years of age and (3) variation in the susceptibility according to the sex of the animals has not been reported [7, 15, 21] . According to these authors, the difference in the ratio of acute versus chronic CBPP formed between both groups might be due to (1) the fact that only cattle with evident clinical signs of CBPP were selected in the former group while in a newly infected herd, nearly a third of the animals developed an acute form, (2) geographical difference in the susceptibility of N'Dama cattle observed between some African countries and (3) a decline of infection pressure on the "contact" group resulting from the rapid death of cattle from the "infected" group but also from the timedependent decrease of the MmmSC strain virulence already described within a herd, although no molecular tools are available to assess this parameter.
Therefore, animals with total recovery were characterised by the highest magnitude of the MmmSC-specific CD4 T-cell response, likely responsible for a more efficient control of the MmmSC infection before the development of lung lesions. The long-term protection developed in these animals should thus rely on the ability of these memory T-cells, after a new antigen encounter, to rapidly adopt an effector phenotype, migrate to the site of infection and trigger a faster and stronger response [11, 12] . Indeed, memory cells, in contrast to naive cells, are activated at lower antigen concentration and are less dependent on costimulation factors leading to higher response even at the early onset of infection [13] . Future studies will focus on the anamnestic response triggered by a second MmmSC challenge to help confirm the protective mechanism. Nevertheless, the induction and expansion of this subset of MmmSCspecific CD4 memory T-cells appear to be one of the required goals in order to develop efficient long-term protective vaccines against CBPP.
